RXST vs. TRML
Compare and contrast key facts about RxSight, Inc. (RXST) and Tourmaline Bio Inc. (TRML).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RXST or TRML.
Performance
RXST vs. TRML - Performance Comparison
Returns By Period
In the year-to-date period, RXST achieves a 11.14% return, which is significantly higher than TRML's -8.33% return.
RXST
11.14%
-11.30%
-27.47%
61.77%
N/A
N/A
TRML
-8.33%
-15.21%
76.08%
36.44%
N/A
N/A
Fundamentals
| RXST | TRML | |
|---|---|---|
| Market Cap | $1.82B | $602.60M |
| EPS | -$0.81 | -$2.49 |
| Total Revenue (TTM) | $138.39M | $2.28M |
| Gross Profit (TTM) | $87.81M | $1.12M |
| EBITDA (TTM) | -$30.52M | -$71.01M |
Key characteristics
| RXST | TRML | |
|---|---|---|
| Sharpe Ratio | 1.10 | 0.44 |
| Sortino Ratio | 1.90 | 1.11 |
| Omega Ratio | 1.23 | 1.16 |
| Calmar Ratio | 1.61 | 0.42 |
| Martin Ratio | 3.82 | 0.73 |
| Ulcer Index | 15.36% | 49.08% |
| Daily Std Dev | 53.31% | 82.03% |
| Max Drawdown | -48.21% | -94.97% |
| Current Drawdown | -30.30% | -70.97% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between RXST and TRML is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
RXST vs. TRML - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for RxSight, Inc. (RXST) and Tourmaline Bio Inc. (TRML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RXST vs. TRML - Dividend Comparison
Neither RXST nor TRML has paid dividends to shareholders.
| TTM | 2023 | |
|---|---|---|
RXST RxSight, Inc. | 0.00% | 0.00% |
TRML Tourmaline Bio Inc. | 0.00% | 57.75% |
Drawdowns
RXST vs. TRML - Drawdown Comparison
The maximum RXST drawdown since its inception was -48.21%, smaller than the maximum TRML drawdown of -94.97%. Use the drawdown chart below to compare losses from any high point for RXST and TRML. For additional features, visit the drawdowns tool.
Volatility
RXST vs. TRML - Volatility Comparison
The current volatility for RxSight, Inc. (RXST) is 13.75%, while Tourmaline Bio Inc. (TRML) has a volatility of 14.88%. This indicates that RXST experiences smaller price fluctuations and is considered to be less risky than TRML based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RXST vs. TRML - Financials Comparison
This section allows you to compare key financial metrics between RxSight, Inc. and Tourmaline Bio Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities